Statement on Medicaid Cuts in Federal Reconciliation Package
Allergy & Asthma Network is deeply concerned by the proposed $880 billion cuts to Medicaid outlined in the federal reconciliation package.
Allergy & Asthma Network is deeply concerned by the proposed $880 billion cuts to Medicaid outlined in the federal reconciliation package.
This webinar discusses current anphylaxis guidelines, emerging therapies, and evidence-based approaches to improve patient outcomes.
This webinar delves into the latest advancements in understanding, diagnosing, and managing Eosinophilic Esophagitis (EoE).
While ordinary drugs will always have a place in healthcare, biologics are, in many ways, the future of medicine.
This webinar discusses evidence-based strategies for managing allergic rhinitis, including the latest treatments and emerging therapies.
This webinar focuses on fostering a healthy, diverse microbiome to reduce the burden of some chronic conditions.
In this webinar, you’ll gain a comprehensive understanding of how marijuana use can affect those living with asthma.
In this webinar, learn all about biologics, how they work and who might benefit from using them as a treatment.
In this webinar, learn about new vaccines available, new vaccine guidelines and how to address vaccine hesitancy.
In this webinar, learn more about the consensus statement and the outcomes of the working group.
This webinar provides tools and strategies for overcoming barriers to medical care.
In this webinar, learn how chronic urticaria is diagnosed, treated and managed long-term.
End of content
End of content

10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Join Our Newsletter
Keep up with the latest news from AAN, right in your inbox! Choose from our E-Newsletter, Research or EXHALE newsletters.
🔐 We do not share or sell your information.